Señales en vivo de 002898.SZ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 03:04):

Sailong Pharmaceutical Group Co., Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China...

Stats
Volumen de hoy	3.13M
Volumen promedio	8.51M
Capitalización de mercado	1.71B
EPS	CNY0.00760 ( 2023-09-30 )
Próxima fecha de ganancias	( CNY0 ) 2024-05-16
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	193.80
ATR14	CNY0.00900 (0.09%)

Volumen Correlación

Largo: -0.05 (neutral)

Corto: 0.54 (weak)

Signal:(46.659) Neutral

Sailong Pharmaceutical Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sailong Pharmaceutical Correlación - Moneda/Commodity

-0.30
( neutral )

-0.35
( neutral )

0.00
( neutral )

0.22
( neutral )

Sailong Pharmaceutical Finanzas

Annual	2023
Ingresos:	CNY310.63M
Beneficio Bruto:	CNY143.47M (46.19 %)
EPS:	CNY0.0542

FY	2023
Ingresos:	CNY310.63M
Beneficio Bruto:	CNY143.47M (46.19 %)
EPS:	CNY0.0542

FY	2022
Ingresos:	CNY264.19M
Beneficio Bruto:	CNY141.25M (53.47 %)
EPS:	CNY-0.210

FY	2021
Ingresos:	CNY247.08M
Beneficio Bruto:	CNY163.61M (66.22 %)
EPS:	CNY-0.133

Financial Reports:

No articles found.

Sailong Pharmaceutical

Sailong Pharmaceutical Group Co., Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, gaicycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, and pantoprazole sodium products. It provides its products for therapeutic areas, such as cardiovascular, cerebrovascular, nerve, digestive system, proton pump inhibitors, anti-infectives, anti-bleeding medicine, analgesics, and other fields. The company was formerly known as Zhuhai Sailong Pharmaceutical Co.,Ltd. and changed its name to Sailong Pharmaceutical Group Co., Ltd. in September 2021. Sailong Pharmaceutical Group Co., Ltd. was founded in 2002 and is based in Zhuhai, China.